Product request:
COVID-19 ExactSign Antigen Nasal Layman Rapid Test (Self-Test) CE Certified (1 Piece)
Qualitative detection of SARS-CoV-2 / COVID-19 antigens
The COVID-19 Antigen Rapid Test is a lateral flow immunoassay method for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in the anterior nasal swab of individuals suspected of having COVID-19 infection.
For this purpose, a sample is taken from the anterior nasal region and applied to a test cassette. The test works according to the lateral flow principle and indicates within 15 minutes whether COVID-19 antigens could be detected in the sample. After 30 minutes, the displayed result is invalid.
- CE certified and reimbursable test listed on EU Common list of COVID-19 rapid antigen tests - No.: 1876, Certified: CE1434 and evaluated by the Paul Ehrlich Institute.
- Result after 15 minutes
- Reliably rule out Sars-CoV-2 infection with high accuracy
- Performable with the aid of an anterior nasal swab
- The test is developed as a point of care (POC). No equipment is required, all consumables are included
Test principle
Unlike an antibody test, the antigen rapid test can directly detect the causative agent of COVID-19, the coronavirus SARS-CoV-2. It detects the proteins of the virus (the antigens). These are found in the anterior nasal swab when the virus replicates there. The antigen rapid test is thus sensitive, similar to the PCR test, especially in the initial phase of the infection. Similar to the PCR test, it can also indicate a viral infection before symptoms appear.
Data
- Assay Type: Lateral Flow PoC Test
- Test type: Qualitative
- Duration: about 13-15 minutes
- Storage temperature: 2 - 30°C
- Sensitivity: 94.4
- Specificity: 100%
Manufacturer | medienkraftwerk |
---|---|
Weight | 0,02 kg |
Delivery time: | 1-3 workdays |
Print data sheets / assembly instructions / catalog / videos / schedules
Other
|